Pharmacological Activation of GPR68 Attenuates Ferroptosis in Spinal Cord Ischemia/Reperfusion Injury Through PI3K/Akt-Mediated Nrf2 Antioxidant Pathway
Open Access
- 18 June 2025
- journal article
- research article
- Published by Springer Nature in Inflammation
- Vol. 48 (6) , 4289-4301
Abstract
Spinal cord ischemia-reperfusion injury (SCIRI) is a devastating condition with limited therapeutic options. This study unveils a novel role of G protein-coupled receptor 68 (GPR68), a pH-sensing G protein-coupled receptor (GPCR), in mitigating ferroptosis—a lipid peroxidation-driven cell death—through the Phosphoinositide 3-Kinase/ Protein Kinase B/ Nuclear Factor Erythroid 2-Related Factor 2 (PI3K/Akt/Nrf2) antioxidant axis. Using in vitro (Oxygen-Glucose Deprivation/Reperfusion (OGD/R)-treated Pheochromocytoma Cell Line 12 (PC12) cells ) and in vivo (rat spinal cord ischemia-reperfusion (I/R) ) models, we demonstrate that GPR68 downregulation exacerbates ferroptosis, evidenced by elevated Acyl-CoA Synthetase Long-Chain Family Member 4 (ACSL4), Malondialdehyde (MDA), and Oxidized Glutathione/ Total Glutathione (GSSG/T-GSH) levels, alongside reduced Solute Carrier Family 7 Member 11 (SLC7A11) and Glutathione Peroxidase 4 (GPX4). Pharmacological activation of GPR68 with MS48107 or the clinically approved benzodiazepine Lorazepam robustly reversed ferroptosis by enhancing Akt phosphorylation and Nrf2 nuclear translocation. Mechanistically, GPR68 siRNA or PI3K/Akt inhibition abolished these protective effects. Crucially, Lorazepam rescued neuronal viability and suppressed ferroptosis in spinal I/R rats, effects fully negated by the GPR68 antagonist Ogremorphin (OGM). Our findings establish GPR68 as a key ferroptosis regulator and propose repurposing Lorazepam as a therapeutic strategy for SCIRI.Keywords
This publication has 33 references indexed in Scilit:
- Nrf2 Signaling Pathway: Focus on Oxidative Stress in Spinal Cord InjuryMolecular Neurobiology, 2024
- Neuroprotection and mechanisms of ginsenosides in nervous system diseases: Progress and perspectivesIUBMB Life, 2024
- ATF4 in cellular stress, ferroptosis, and cancerArchives of Toxicology, 2024
- Hydroxysafflor yellow A and anhydrosafflor yellow B alleviate ferroptosis and parthanatos in PC12 cells injured by OGD/RFree Radical Biology and Medicine, 2022
- Ferroptosis and its potential as a therapeutic targetBiochemical Pharmacology, 2021
- Longxuetongluo Capsule protects against cerebral ischemia/reperfusion injury through endoplasmic reticulum stress and MAPK-mediated mechanismsJournal of Advanced Research, 2021
- Nrf2-Keap1 signaling in oxidative and reductive stressBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2018
- Applications of the Keap1–Nrf2 system for gene and cell therapyFree Radical Biology and Medicine, 2015
- Acidic pH increases cGMP accumulation through the OGR1/phospholipase C/Ca2+/neuronal NOS pathway in N1E-115 neuronal cellsCellular Signalling, 2014
- The roles of acid-sensing ion channel 1a and ovarian cancer G protein-coupled receptor 1 on passive Mg2+ transport across intestinal epithelium-like Caco-2 monolayersThe Journal of Physiological Sciences, 2014